Abstract 1830: SP09253, an orally bioavailable, highly potent RAS(ON) molecular glue inhibitor demonstrates robust anti-tumor activity in KRAS-mutant tumors.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Zherong Zhang, Xiaoyu Di, Qiming Sun
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148720893